Anika Therapeutics, Inc.
Nasdaq · CIK 0000898437 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$62.2M
Cost Of Revenue
$22.0M
Gross Profit
$40.2M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $62.2M | - | - |
| Cost Of Revenue | $22.0M | - | - |
| Gross Profit | $40.2M | - | - |
| Operating Income | $-2.5M | - | - |
| Net Income | $-1.7M | - | - |
| Eps Basic | -0.13 | - | - |
| Eps Diluted | -0.13 | - | - |
| Cash And Equivalents | $38.4M | - | - |
| Total Assets | $183.5M | - | - |
| Shareholders Equity | $137.3M | - | - |
| Operating Cash Flow | $-5.5M | - | - |
| Capital Expenditures | $2.9M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Anika Therapeutics, Inc. | 2026-07-29 | 0001171843-26-005012 |
| 4 | Anika Therapeutics, Inc. | 2026-06-23 | 0001193125-26-279545 |
| 4 | Anika Therapeutics, Inc. | 2026-06-23 | 0001193125-26-279542 |
| 4 | Anika Therapeutics, Inc. | 2026-06-23 | 0001193125-26-279541 |
| 4 | Anika Therapeutics, Inc. | 2026-06-23 | 0001193125-26-279539 |
| 4 | Anika Therapeutics, Inc. | 2026-06-23 | 0001193125-26-279535 |
| 4 | Anika Therapeutics, Inc. | 2026-06-05 | 0001193125-26-259520 |
| 4 | Anika Therapeutics, Inc. | 2026-05-04 | 0001193125-26-202704 |
| 4 | Anika Therapeutics, Inc. | 2026-04-30 | 0001193125-26-197887 |
| 10-Q | Anika Therapeutics, Inc. | 2026-04-30 | 0001171843-26-002852 |
| 4 | Anika Therapeutics, Inc. | 2026-03-17 | 0001193125-26-111494 |
| 4 | Anika Therapeutics, Inc. | 2026-03-17 | 0001193125-26-111492 |
| 4 | Anika Therapeutics, Inc. | 2026-03-17 | 0001193125-26-111511 |
| 4 | Anika Therapeutics, Inc. | 2026-03-17 | 0001193125-26-111502 |
| 4 | Anika Therapeutics, Inc. | 2026-03-11 | 0001193125-26-102240 |
| 4 | Anika Therapeutics, Inc. | 2026-03-11 | 0001193125-26-102239 |
| 4 | Anika Therapeutics, Inc. | 2026-03-11 | 0001193125-26-102238 |
| 10-K | Anika Therapeutics, Inc. | 2026-03-03 | 0001171843-26-001275 |
| 10-Q | Anika Therapeutics, Inc. | 2025-11-05 | 0001171843-25-007032 |
| 10-Q | Anika Therapeutics, Inc. | 2025-07-30 | 0001171843-25-004826 |